Logan Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-79,419
| Closed | -$17.6M | – | 276 |
|
|
2025
Q4 | $18.1M | Sell |
79,419
-8,592
| -10% | -$1.96M | 0.76% | 28 |
|
|
2025
Q3 | $20.4M | Sell |
88,011
-2,301
| -3% | -$469K | 0.86% | 25 |
|
|
2025
Q2 | $16.8M | Sell |
90,312
-23,791
| -21% | -$4.42M | 0.78% | 26 |
|
|
2025
Q1 | $23.9M | Buy |
114,103
+4,465
| +4% | +$868K | 1.09% | 18 |
|
|
2024
Q4 | $19.5M | Sell |
109,638
-878
| -0.8% | -$161K | 0.82% | 28 |
|
|
2024
Q3 | $21.8M | Buy |
110,516
+192
| +0.2% | +$35.8K | 0.9% | 24 |
|
|
2024
Q2 | $18.9M | Sell |
110,324
-1,089
| -1% | -$180K | 0.82% | 29 |
|
|
2024
Q1 | $20.3M | Sell |
111,413
-6,128
| -5% | -$1.06M | 0.87% | 31 |
|
|
2023
Q4 | $18.2M | Sell |
117,541
-4,832
| -4% | -$704K | 0.85% | 30 |
|
|
2023
Q3 | $18.2M | Buy |
122,373
+6,681
| +6% | +$981K | 0.93% | 27 |
|
|
2023
Q2 | $15.6M | Buy |
115,692
+2,222
| +2% | +$326K | 0.75% | 37 |
|
|
2023
Q1 | $18.1M | Sell |
113,470
-4,626
| -4% | -$707K | 0.88% | 31 |
|
|
2022
Q4 | $19.1M | Buy |
118,096
+29,827
| +34% | +$4.57M | 0.98% | 23 |
|
|
2022
Q3 | $11.8M | Sell |
88,269
-254
| -0.3% | -$36.4K | 0.71% | 44 |
|
|
2022
Q2 | $13.6M | Sell |
88,523
-11,809
| -12% | -$1.8M | 0.78% | 42 |
|
|
2022
Q1 | $16.3M | Sell |
100,332
-5,353
| -5% | -$778K | 0.79% | 37 |
|
|
2021
Q4 | $14.3M | Sell |
105,685
-2,622
| -2% | -$310K | 0.62% | 45 |
|
|
2021
Q3 | $11.7M | Buy |
108,307
+6,819
| +7% | +$779K | 0.54% | 57 |
|
|
2021
Q2 | $11.4M | Buy |
101,488
+136
| +0.1% | +$15.3K | 0.53% | 59 |
|
|
2021
Q1 | $11M | Buy |
101,352
+54
| +0.1% | +$5.78K | 0.55% | 58 |
|
|
2020
Q4 | $10.9M | Sell |
101,298
-11,121
| -10% | -$1.07M | 0.54% | 56 |
|
|
2020
Q3 | $9.85M | Sell |
112,419
-4,579
| -4% | -$431K | 0.53% | 57 |
|
|
2020
Q2 | $11.5M | Sell |
116,998
-18,374
| -14% | -$1.62M | 0.66% | 46 |
|
|
2020
Q1 | $10.3M | Sell |
135,372
-4,198
| -3% | -$358K | 0.72% | 41 |
|
|
2019
Q4 | $12.4M | Sell |
139,570
-6,606
| -5% | -$548K | 0.68% | 44 |
|
|
2019
Q3 | $11.1M | Sell |
146,176
-585
| -0.4% | -$40.1K | 0.65% | 45 |
|
|
2019
Q2 | $10.7M | Buy |
146,761
+19,770
| +16% | +$1.55M | 0.63% | 49 |
|
|
2019
Q1 | $10.2M | Buy |
126,991
+1,211
| +1% | +$99.1K | 0.63% | 50 |
|
|
2018
Q4 | $11.6M | Sell |
125,780
-270
| -0.2% | -$23.7K | 0.92% | 34 |
|
|
2018
Q3 | $11.9M | Buy |
126,050
+361
| +0.3% | +$34.2K | 0.78% | 40 |
|
|
2018
Q2 | $11.6M | Buy |
125,689
+1,907
| +2% | +$186K | 0.81% | 38 |
|
|
2018
Q1 | $11.7M | Sell |
123,782
-21,392
| -15% | -$2.35M | 0.82% | 41 |
|
|
2017
Q4 | $14M | Sell |
145,174
-10,292
| -7% | -$970K | 0.98% | 33 |
|
|
2017
Q3 | $13.8M | Buy |
155,466
+200
| +0.1% | +$15.2K | 0.99% | 34 |
|
|
2017
Q2 | $11.3M | Sell |
155,266
-6,995
| -4% | -$470K | 0.84% | 41 |
|
|
2017
Q1 | $10.6M | Buy |
162,261
+1,185
| +0.7% | +$74.5K | 0.81% | 43 |
|
|
2016
Q4 | $10.1M | Sell |
161,076
-426
| -0.3% | -$26K | 0.81% | 43 |
|
|
2016
Q3 | $10.2M | Buy |
161,502
+5,163
| +3% | +$334K | 0.83% | 44 |
|
|
2016
Q2 | $9.68M | Sell |
156,339
-40,679
| -21% | -$2.48M | 0.82% | 44 |
|
|
2016
Q1 | $11.3M | Buy |
197,018
+177,152
| +892% | +$9.87M | 0.91% | 38 |
|
|
2015
Q4 | $1.18M | Sell |
19,866
-148
| -0.7% | -$8.52K | 0.09% | 138 |
|
|
2015
Q3 | $1.09M | Buy |
20,014
+219
| +1% | +$14.3K | 0.09% | 139 |
|
|
2015
Q2 | $1.33M | Sell |
19,795
-390
| -2% | -$25.5K | 0.1% | 133 |
|
|
2015
Q1 | $1.18M | Sell |
20,185
-640
| -3% | -$38.7K | 0.08% | 138 |
|
|
2014
Q4 | $1.36M | Sell |
20,825
-600
| -3% | -$37.8K | 0.1% | 131 |
|
|
2014
Q3 | $1.24M | Buy |
21,425
+120
| +0.6% | +$6.66K | 0.09% | 123 |
|
|
2014
Q2 | $1.2M | Sell |
21,305
-601
| -3% | -$31.5K | 0.09% | 129 |
|
|
2014
Q1 | $1.13M | Buy |
21,906
+220
| +1% | +$11.1K | 0.08% | 137 |
|
|
2013
Q4 | $1.15M | Sell |
21,686
-532
| -2% | -$26.1K | 0.08% | 140 |
|
|
2013
Q3 | $994K | Buy |
+22,218
| New | +$985K | 0.07% | 141 |
|
Other funds holding ABBV
VCM
VPM
Logan Capital Management's ABBV Position: Q1 2026 in Review
Logan Capital Management sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 79,419 shares — an estimated $17.6M sold.
Logan Capital Management first reported a position in ABBV in Q3 2013 and held it in 50 quarters. The position peaked at $23.9M in Q1 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Logan Capital Management reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
- Logan Capital Management sold 79,419 AbbVie shares in Q1 2026, an estimated $17.6M.
- Logan Capital Management first reported a position in AbbVie in Q3 2013 and held it in 50 quarters.
- Logan Capital Management's AbbVie position peaked at $23.9M in Q1 2025.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Logan Capital Management's 13F filing for Q1 2026, filed 8 May 2026.